Casaasdas

A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).

Por um escritor misterioso
Last updated 07 junho 2024
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Analysis of Single‐Cell Transcriptome and Surface Protein Expression in Ankylosing Spondylitis Identifies OX40‐Positive and Glucocorticoid‐Induced Tumor Necrosis Factor Receptor–Positive Pathogenic Th17 Cells - Yi - 2023 - Arthritis & Rheumatology - Wiley
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Full article: Impact of different types of exercise programs on ankylosing spondylitis: a systematic review and meta-analysis
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
/index.php/cjht/article/downlo
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
WO2021067465A1 - Treating spondyloarthritic and psoriatic conditions with upadacitinib - Google Patents
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Full article: POSTER PRESENTATIONS
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial - The Lancet
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Oscar IRVIN-SELLERS, Medigene AG
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Poster Abstract Presentation Abstracts - 2023 - International Journal of Rheumatic Diseases - Wiley Online Library
A. Mean ASDAS and B. mean BASDAI to week 96. Safety set (N = 89).
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial
Recomendado para você
você pode gostar

© 2014-2024 empresaytrabajo.coop. All rights reserved.